Proficiency analysis of drug susceptibility testing by national-level tuberculosis reference laboratories from 1995 to 2003

Journal of Clinical Microbiology

Volumn 45, Issue 11, 2007, Pages 3626-3630

  Bai, Gill Han ^a   Kim, Sang Jae ^b   Chang, Chulhun L ^a,c,d  

^a Korean Institute of Tuberculosis   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pusan National University   (South Korea)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; LABORATORY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 36348936842     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00784-07     Document Type: Article

References (9)

1. Canetti, G., W. Fox, A. Khomenko, et al. 1969. Advances in techniques of testing mycobacterial drug susceptibility testing, and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43.
2. Canetti, G., S. Froman, J. Grosset, et al. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. W. H. O. 29:565-578.
3. Fleiss, J. L. 1981. Statistical methods for rates and proportions. Wiley-Interscience, New York, NY.
4. Kim, S. J. 2005. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur. Respir. J. 25:564-569.
5. Laszlo, A., M. Rahman, M. Espinal, and M. Raviglione. 2002. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int. J. Tuberc. Lung Dis. 6:748-756.
6. Lwanga, S. K., and S. Lemeshow. 1991. Sample size determination in health studies. World Health Organization, Geneva, Switzerland.
7. World Health Organization. 2000. Anti-tuberculosis drug resistance in the world. Report no. 2: prevalence and trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/CDC/TB/2000.278. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/ 2000/WHO_CDS_TB_2000.278_intro.pdf.
8. World Health Organization. 2004. Anti-tuberculosis drug resistance in the world: third global report. The WHO/IUATLD Global Project on Antituberculosis Drug Resistance Surveillance, 1999-2002. WHO/HTM/TB/2004.343. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/ publications/who_htm_tb_2004_343/en/.
9. World Health Organization. 1997. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1994-1997. WHO/TB/97.229. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/1997/WHO_TB_97.229.pdf.